- Home
- ALDX vs BNTC Comparison
ALDX vs BNTC Comparison
Compare ALDX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BNTC
- Stock Information
- Founded
- ALDX 2004
- BNTC 1995
- Country
- ALDX United States
- BNTC United States
- Employees
- ALDX N/A
- BNTC N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ALDX Health Care
- BNTC Health Care
- Exchange
- ALDX Nasdaq
- BNTC Nasdaq
- Market Cap
- ALDX 133.7M
- BNTC 352.5M
- IPO Year
- ALDX 2014
- BNTC N/A
- Fundamental
- Price
- ALDX $2.16
- BNTC $13.74
- Analyst Decision
- ALDX Strong Buy
- BNTC Strong Buy
- Analyst Count
- ALDX 2
- BNTC 7
- Target Price
- ALDX $9.50
- BNTC $24.71
- AVG Volume (30 Days)
- ALDX 1.5M
- BNTC 37.1K
- Earning Date
- ALDX 05-20-2025
- BNTC 05-16-2025
- Dividend Yield
- ALDX N/A
- BNTC N/A
- EPS Growth
- ALDX N/A
- BNTC N/A
- EPS
- ALDX N/A
- BNTC N/A
- Revenue
- ALDX N/A
- BNTC N/A
- Revenue This Year
- ALDX N/A
- BNTC N/A
- Revenue Next Year
- ALDX N/A
- BNTC N/A
- P/E Ratio
- ALDX N/A
- BNTC N/A
- Revenue Growth
- ALDX N/A
- BNTC N/A
- 52 Week Low
- ALDX $1.14
- BNTC $5.74
- 52 Week High
- ALDX $7.20
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- ALDX 34.82
- BNTC 51.06
- Support Level
- ALDX $1.90
- BNTC $13.10
- Resistance Level
- ALDX $2.89
- BNTC $15.69
- Average True Range (ATR)
- ALDX 0.23
- BNTC 0.73
- MACD
- ALDX 0.10
- BNTC -0.01
- Stochastic Oscillator
- ALDX 26.26
- BNTC 24.71
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.